Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes

Aarti Ramanathan, Christos A. Kyratsous|PLoS ONE|2016

Cited by 32